论文部分内容阅读
选取我院60例癫痫患者作为研究对象,随机分为对照组和观察组各30例。对照组单用奥卡西平治疗,观察组使用奥卡西平联合托吡酯治疗,3个月后观察两组的临床疗效和不良反应情况。观察组总有效率为96.67%,明显高于对照组的70.00%,两组差异显著(P<0.05);观察组无不良反应,不良反应率明显低于对照组的13.33%,两组差异显著(P<0.05)。奥卡西平联合托吡酯治疗癫痫,能够提高临床效果,而且能降低不良反应率,值得临床推广。
60 cases of epilepsy in our hospital were selected as the research object and randomly divided into control group and observation group of 30 cases. The control group was treated with oxcarbazepine alone. The observation group was treated with oxcarbazepine and topiramate. The clinical efficacy and adverse reactions of the two groups were observed after 3 months. The total effective rate in the observation group was 96.67%, which was significantly higher than that in the control group (70.00%) (P <0.05). There was no adverse reaction in the observation group and the adverse reaction rate was significantly lower than that in the control group (13.33% (P <0.05). The combination of oxcarbazepine and topiramate in treating epilepsy can improve the clinical effect and reduce the adverse reaction rate, which is worthy of clinical promotion.